Profile
Full Name
Design Therapeutics, Inc.Ticker Symbol
DSGNExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
March 29, 2021Indexes
Not includedWebsite
http://www.designtx.comEmployees
54Key Details
Price
$3.50(+3.55%)
Market cap
$198.67M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.88(+26.05% YoY)
PE ratio
-
Next earnings date
May 8, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Design Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Aug 6, 24 RBC Capital
Sector PerformMay 7, 24 Piper Sandler
OverweightMar 20, 24 Wedbush
NeutralMar 20, 24 RBC Capital
Sector PerformNov 14, 23 RBC Capital
Sector PerformAug 15, 23 Wedbush
NeutralAug 15, 23 SVB Leerink
Market PerformAug 15, 23 RBC Capital
Sector PerformMay 10, 23 Wedbush
OutperformMay 10, 23 RBC Capital
OutperformInstitutional Ownership
- What is the ticker symbol for Design Therapeutics?
- Does Design Therapeutics pay dividends?
- What sector is Design Therapeutics in?
- What industry is Design Therapeutics in?
- What country is Design Therapeutics based in?
- When did Design Therapeutics go public?
- Is Design Therapeutics in the S&P 500?
- Is Design Therapeutics in the NASDAQ 100?
- Is Design Therapeutics in the Dow Jones?
- When was Design Therapeutics's last earnings report?
- When does Design Therapeutics report earnings?
- Should I buy Design Therapeutics stock now?
What is the ticker symbol for Design Therapeutics?
The ticker symbol for Design Therapeutics is NASDAQ:DSGN
Does Design Therapeutics pay dividends?
No, Design Therapeutics does not pay dividends
What sector is Design Therapeutics in?
Design Therapeutics is in the Healthcare sector
What industry is Design Therapeutics in?
Design Therapeutics is in the Biotechnology industry
What country is Design Therapeutics based in?
Design Therapeutics is headquartered in United States
When did Design Therapeutics go public?
Design Therapeutics's initial public offering (IPO) was on March 29, 2021
Is Design Therapeutics in the S&P 500?
No, Design Therapeutics is not included in the S&P 500 index
Is Design Therapeutics in the NASDAQ 100?
No, Design Therapeutics is not included in the NASDAQ 100 index
Is Design Therapeutics in the Dow Jones?
No, Design Therapeutics is not included in the Dow Jones index
When was Design Therapeutics's last earnings report?
Design Therapeutics's most recent earnings report was on Mar 10, 2025
When does Design Therapeutics report earnings?
The next expected earnings date for Design Therapeutics is May 8, 2025
Should I buy Design Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions